Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant evidence into real-world patient management.
This educational activity is an archive of the live symposium held on November 21, 2025.
Target Audience
This educational activity is directed toward psychiatrists who treat patients with a range of psychiatric disorders. Psychiatric nurse practitioners, psychiatric nurses, pharmacists, and other health care professionals interested in the treatment of patients with psychiatric disorders are invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify novel therapeutic targets for major depressive disorder
- Evaluate clinical trial data for glutamatergic therapies for major depressive disorder
- Develop individualized management plans for patients who are not responding to standard anti-depressant therapy
Juan D. Oms, MD, FAPA
Residency Program Director
Southern Winds Hospital
Voluntary Assistant Professor
Department of Psychiatry
Florida International University
Miami, FL
Juan D. Oms, MD, FAPA, has no relevant financial relationships with ineligible companies.
Linda Collado, MD, DABPN, FAPA
Associate
Program Director
Department
of Psychiatry
Banyan
Health Systems
Miami, FL
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: Bristol Myers Squibb
Ginger Shupe, MD
Medical
Director of Outpatient
Psychiatry
Larkin
Community Hospital
South
Miami, FL
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: AbbVie, Axsome Therapeutics, Bristol Myers Squibb; Grant/ResearchFunding (to institution): Quantix Research LLC
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here